SATISFY-CA · Mitapivat and Provide Proof of Concept of the Efficacy of the Drug · RBC Membranopathies or CDAII
Primary completion pushed from Jun 30, 2026 to Oct 2029
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 30, 2027 to Oct 2029
University Health Network, TorontoPhase 2 NCT07055243 Registry history of NCT07055243 on ClinicalTrials.gov (opens the registry)